Moderna (MRNA) set to cure COVID-19 – is now the time to invest?

MRNA’s key COVID-19 developments so far US government is willing to fund mRNA-173 through every trial until regulatory approval. Biomedical Advanced Research and Development Authority (BARDA) is ready to give Moderna (NASDAQ: MRNA) $483 million to expedite mRNA-173 through clinical development. Lonza Group, via its agreement with Moderna, is manufacturing mRNA-173 at their US and […]

Hoth Therapeutics gaining ground in the race for a COVID-19 vaccine

In recent weeks, Biotech companies across the globe have been collaborating together to produce a COVID-19 vaccine for global production and distribution. The reward for such an accomplishment would add prestige and intrinsic value at a scale we have never witnessed. The vaccine will save millions of lives in the years to follow, as well as […]